Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

| More on:
A woman wearing a yellow shirt smiles as she checks her phone.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • Bell Potter has initiated coverage on Orica with a buy rating and a $23.00 price target, citing its transformation and expected growth in underlying EBIT, along with potential for increased shareholder returns through share buy-backs and dividends
  • Citi has upgraded Pro Medicus to a buy rating with a $350.00 target, highlighting its strong earnings growth outlook supported by long-term contracts, high renewal rates, and the potential growth facilitated by artificial intelligence.
  • UBS has maintained its buy rating on Zip Co with a price target of $5.25, driven by strong app download data in July and August indicating continued momentum and a positive outlook for FY 2026.

It has been another busy week for many of Australia's top brokers. This has led to the release of a number of broker notes.

Three broker buy ratings that you might want to know more about are summarised below. Here's why brokers think these ASX shares are in the buy zone right now:

Orica Ltd (ASX: ORI)

According to a note out of Bell Potter, its analysts have initiated coverage on this commercial explosives company's shares with a buy rating and $23.00 price target. The broker is feeling positive about Orica's outlook following its transformation in recent years. In fact, it expects the company to grow underlying EBIT across each segment in the short-to-medium term. Bell Potter also believes that the company is well positioned to deliver rapid de-leveraging over FY 2026 to FY 2027 (in the absence of M&A). It expects this to allow Orica's board to prioritise increasing shareholder returns via an extension to the share buy-back program and dividends. The Orica share price is trading at $21.23 on Friday.

Pro Medicus Ltd (ASX: PME)

A note out of Citi reveals that its analysts have upgraded this health imaging technology company's shares to a buy rating with a significantly improved price target of $350.00. Although Citi concedes that Pro Medicus shares trade on high multiples, it believes this is justified due to its strong earnings growth outlook. It notes that this is being underpinned by its sticky product offering, long contracts, high renewal rates, and an industry challenged by radiologist constraints. The broker has boosted its revenue growth estimates. It also highlights its belief that artificial intelligence will be supportive of Pro Medicus' growth and margin expansion in the medium term. The Pro Medicus share price is fetching $317.63 at the time of writing.

Zip Co Ltd (ASX: ZIP)

Analysts at UBS have retained their buy rating on this buy now pay later (BNPL) provider's shares with an improved price target of $5.25. According to the note, the broker is feeling even more bullish on Zip's outlook after reviewing app store data. It highlights that the data indicates that downloads increased strongly in July and August, which bodes well for its performance in FY 2026 and indicates that its strong momentum is continuing. Especially given how resilient US retail sales have been. In light of this, it has boosted its earnings estimates for the medium term and its valuation to reflect this. The Zip share price is trading at $4.71 this afternoon.

Citigroup is an advertising partner of Motley Fool Money. Motley Fool contributor James Mickleboro has positions in Pro Medicus. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Zip Co. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has recommended Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Smiling man sits in front of a graph on computer while using his mobile phone.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

White declining arrow on a blue graph with an animated man representing a falling share price.
Materials Shares

Experts call time on these rip-snorting ASX 200 mining shares

These 2 ASX 200 mining stocks have risen by 160% and 230%, respectively, over the past 12 months.

Read more »

Two people comparing and analysing material.
Broker Notes

Buy, hold, sell: Netwealth, Santos, and South32 shares

Morgans has given its verdict on these shares following updates.

Read more »

Business man at desk looking out window with his arms behind his head at a view of the city and stock trends overlay.
Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »

Three smiling corporate people examine a model of a new building complex.
Broker Notes

Broker says this ASX All Ords stock could rise 15%

Bell Potter thinks investors should be buying this growing company's shares.

Read more »

A man slumps crankily over his morning coffee as it pours with rain outside.
Broker Notes

Why Lynas shares could crash 33%

Bell Potter believes this rare earths stock could lose a third of its value.

Read more »

Three girls compete in a race, running fast around an athletic track.
Broker Notes

Two ASX 200 stocks to buy after crashing 6-9% yesterday

Bell Potter is tipping an 18-40% resurgence for these stocks.

Read more »

A woman looks quizzical as she looks at a graph of the share market.
Broker Notes

Looking for double-digit returns? Check out RBC Capital Markets' picks ahead of reporting season

These shares could deliver strong upside.

Read more »